SCHEMBL497977

SCHEMBL497977

COc1ccc(-c2cn[nH]c(=O)c2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 6/20 0.55
PDE4B Q07343 6/20 0.55
PDE4C Q08493 6/20 0.55
PDE4D Q08499 6/20 0.55
KDM4E B2RXH2 3/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 1/20 0.51
THRB P10828 1/20 0.51
PDGFRB P09619 1/20 0.49
PDGFRA P16234 1/20 0.49
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
ALOX12 P18054 1/20 0.47
KMT2A Q03164 1/20 0.47
DYRK1A Q13627 3/20 0.46
KIT P10721 1/20 0.46
PDE3B Q13370 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497727 0.84 PDE4A (0.57) PDE4APDE4BPDE4CPDE4D
SCHEMBL1373045 0.80 KMT2A (0.51) KDM4ELMNAMAPTTHRBALDH1A1
SCHEMBL498077 0.79 PDE4D (0.48) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL21590813 0.75 LRRK2 (0.46) MAPTDYRK1APDE3BPDE3ACYP19A1
SCHEMBL8840880 0.74 PDE4A (0.67) PDE4AKDM4ELMNAMAPTTHRB
SCHEMBL5770101 0.74 MEN1 (0.46) KDM4ELMNAALDH1A1HPGDMEN1
SCHEMBL18339224 0.72 MAPK1 (0.48) KDM4EHSD17B10ALDH1A1HPGDKMT2A
SCHEMBL8479743 0.71 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL1423967 0.71 KDM4E (1.00) KDM4ELMNAMAPTHSD17B10ALDH1A1
SCHEMBL27844309 0.70 FGFR1 (0.51) DYRK1ADYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157084-B1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE KOWA CO (JP) 2013-05-22 EP disclosed
US-8106053-B2 5-phenyl-3-pyridazinone derivative KOWA COMPANY, LTD. 2012-01-31 US disclosed
US-20100197698-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE KOWA COMPANY, LTD. (JP) 2010-08-05 US disclosed
EP-2157084-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE Kowa Company, Ltd. (JP) 2010-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197698-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE SERPINE1, MMP1, PLAT PDE4A 2167/4885PDE4B 1932/4885PDE4C 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.